Login to Your Account



As War Looms, Sector Could Have 'Biggest Product Year Ever'

By Randall Osborne


Monday, February 3, 2003

With 20 drugs approved last year, a somewhat brightened market picture in the final quarter of 2002 and Phase III data due in the months ahead, analysts are finding cause for optimism even as the rumblings of war grow louder.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription